IP Library Granted Patent US 7,291,168
Granted Patent B2
US 7,291,168 · App. 10/695,433 · Granted Nov 6, 2007

Methods and devices for heart valve treatments

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,291,168
App. No.
10/695,433
Filed
Oct 28, 2003
Granted
Nov 6, 2007
Kind
B2
Art Unit
3738
USPC
623/1.1
Abstract

The present invention is a group of medical devices designed to improve heart valve function. The medical devices may be used individually, or in combination to supplement damaged valves, replace damaged valves, or improve damaged valves function. The medical devices include leaflet retainers, a neo-annulus, neo-leaflet, and a framework. In addition, the present invention is novel methods for surgically treating heart valves.

Claims (9)

1. A method comprising

providing a heart implant sized and configured to be positioned in a left atrium above the plane of a native mitral heart valve annulus having leaflets, the implant including a portion sized and configured for engagement with a wall of the left atrium above the plane of the native mitral valve annulus to interact with movement of the leaflets of the mitral heart valve to affect mitral heart valve function,

establishing an intravascular access path that extends from a right atrium through a septum and into a left atrium,

deploying the implant through the intravascular path into the left atrium, and

positioning the implant in the left atrium with the portion engaging a wall of the left atrium above the plane of the native mitral valve annulus such that the portion interacts with movement of the leaflets of the mitral heart valve to affect mitral heart valve function.

2. A method according to claim 1 wherein the implant is positioned so that the portion spans the left atrium.

3. A method according to claim 1 wherein the implant is positioned so that the portion changes the shape of the native mitral heart valve annulus.

4. A method according to claim 1 wherein the heart implant comprises, at least in part, nitinol, dacron, polytetrafluoroethylene, silicon, polyurethane, human pericardium, or animal pericardium.

5. A method according to claim 1 wherein the heart implant comprises, at least in part, a super elastic material.